HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat

[1]  R. Fariello,et al.  Nigral degeneration in acquired immune deficiency syndrome (AIDS) , 2004, Acta Neuropathologica.

[2]  A. Nath,et al.  Human immunodeficiency virus‐1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function , 2002, Journal of neurochemistry.

[3]  F. Kashanchi,et al.  Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals , 2002, BMC Biochemistry.

[4]  I. Hewlett,et al.  Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. , 2002, Journal of biomedical science.

[5]  S. Barger,et al.  Pro‐inflammatory and pro‐oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β‐estradiol , 2001, Journal of neurochemistry.

[6]  M. Iyo,et al.  Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. , 2001, The American journal of psychiatry.

[7]  A. Gow,et al.  Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment , 2001, Brain Research Reviews.

[8]  A. Bansal,et al.  Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum , 2001, Neuroscience Letters.

[9]  J S Fowler,et al.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. , 2001, The American journal of psychiatry.

[10]  A. Bansal,et al.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.

[11]  D. Butterfield,et al.  Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase , 2000, Brain Research.

[12]  T. Bottiglieri,et al.  Decreased Homovanilic Acid in Cerebrospinal Fluid Correlates with Impaired Neuropsychologic Function in HIV-1-Infected Patients , 2000, Clinical neuropharmacology.

[13]  L. Rodella,et al.  HIV-1 Tat-mediated Inhibition of the Tyrosine Hydroxylase Gene Expression in Dopaminergic Neuronal Cells* , 2000, The Journal of Biological Chemistry.

[14]  S. Imam,et al.  Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation , 2000, Brain Research.

[15]  M. W. Manning,et al.  Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine , 1999, The Journal of Neuroscience.

[16]  M. LaVoie,et al.  Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.

[17]  F. Silverstein,et al.  Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats , 1999, Neuroscience.

[18]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[19]  D. Wong,et al.  Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428 , 1998, The Journal of Neuroscience.

[20]  B. Yamamoto,et al.  The effects of methamphetamine on the production of free radicals and oxidative stress. , 1998, The Journal of pharmacology and experimental therapeutics.

[21]  S. Mirsattari,et al.  Parkinsonism with HIV infection , 1998, Movement disorders : official journal of the Movement Disorder Society.

[22]  M. W. Manning,et al.  Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats , 1998, Neuroscience Letters.

[23]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[24]  A. Nath,et al.  Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms , 1998, Progress in Neurobiology.

[25]  J. Busciglio,et al.  Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. , 1998, Journal of neurovirology.

[26]  A. Nath,et al.  Molecular Determinants for Cellular Uptake of Tat Protein of Human Immunodeficiency Virus Type 1 in Brain Cells , 1996 .

[27]  A. Nath,et al.  HIV dementia and the basal ganglia. , 1997, Intervirology.

[28]  W. Cass.  Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. , 1997, The Journal of pharmacology and experimental therapeutics.

[29]  W. Cass,et al.  GDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine , 1996, The Journal of Neuroscience.

[30]  D. Kolson,et al.  AIDS Dementia and HIV-1-Induced Neurotoxicity: Possible Pathogenic Associations and Mechanisms. , 1996, Journal of biomedical science.

[31]  C. Vorhees,et al.  α‐Phenyl‐N‐tert‐butyl nitrone attenuates methamphetamine‐induced depletion of striatal dopamine without altering hyperthermia , 1996, Synapse.

[32]  E. Floor,et al.  Amphetamine releases dopamine from synaptic vesicles by dual mechanisms , 1996, Neuroscience Letters.

[33]  A. Levey,et al.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.

[34]  G. Reynolds,et al.  Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS , 1996, Neuroreport.

[35]  D. Sulzer,et al.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  M. Zigmond,et al.  Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine , 1995, Journal of neurochemistry.

[37]  J. Carlson,et al.  Estimating Extracellular Concentrations of Dopamine and 3,4‐Dihydroxyphenylacetic Acid in Nucleus Accumbens and Striatum Using Microdialysis: Relationships Between In Vitro and In Vivo Recoveries , 1994, Journal of neurochemistry.

[38]  D. Sulzer,et al.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  C. Epstein,et al.  Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1994, Journal of neurochemistry.

[40]  B. Levin,et al.  Cerebrospinal fluid dopamine in HIV‐1 infection , 1994, AIDS.

[41]  D. Segal,et al.  Amphetamine and its analogs : psychopharmacology, toxicology, and abuse , 1994 .

[42]  J. McCord,et al.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Arbuthnott,et al.  Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus , 1993, Neuroscience.

[44]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[45]  L. Montagnier,et al.  Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion , 1992, Annals of neurology.

[46]  K. Kieburtz,et al.  Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications. , 1991, Archives of neurology.

[47]  B. Bunney,et al.  Ionic Composition of Microdialysis Perfusing Solution Alters the Pharmacological Responsiveness and Basal Outflow of Striatal Dopamine , 1989, Journal of neurochemistry.

[48]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .